LGR5: from stem cell marker to therapeutic target.

Peyton C High1, Maya G Cappellino1, Tiffani A Blackburn1

  • 1Center for Translational Cancer Research, The Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030, USA; The University of Texas MD Anderson Cancer Center, UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX 77030, USA.

Trends in Cancer
|April 6, 2026
PubMed
Summary

Leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5) is a key marker in cancer stem cells, driving tumor growth and resistance. Targeting LGR5 shows promise for effective cancer therapies.